LAKE FOREST, Calif.--(BUSINESS WIRE)--
STAAR Surgical Company (STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced today that the Company will host an Investor and Analyst Day on Friday, November 8, 2019 in New York City at 8:30 a.m. EST. The event will detail STAAR’s Vision for the 2020-2022 three-year planning period and include presentations by ophthalmic surgeons. Due to limited capacity, attendance at the Investor and Analyst Day is by invitation only.
A webcast with accompanying slides of a presentation by Caren Mason, President and CEO of STAAR Surgical, and a presentation by Dr. Mark Packer will be available on the “Investors” page of the Company's website at https://www.staar.com/. A replay of the webcast will also be available on the Company's website following the event.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL”, which includes the EVO Visian ICL™ product line. More than 1,000,000 Visian® ICLs have been implanted to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company’s website at www.staar.com.